India’s pharmaceutical exports increase 6.8% year-on-year to $8.1 billion in Q1 FY27, according to Business Line and Times of India. The outlets also note that vaccine shipments grow faster, rising 36% over the same period. In Business Line’s report, exports in June alone climb 7.13% year-on-year to $2.81 billion, and are higher than May FY27 levels.
The reporting attributes the rise to sustained global demand for Indian pharma products. Business Line provides more month-level detail, stating June exports are up 6.86% compared with $2.63 billion in May FY27. Times of India focuses more broadly on the quarter-wide growth figure and the role of global demand, without providing additional month-to-month numbers in the excerpt provided. Overall, both sources agree on the headline quarter growth rate and the strong performance of vaccine exports.
